Copyright Reports & Markets. All rights reserved.

Global Vascular Endothelial Growth Factor B Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Vascular Endothelial Growth Factor B Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Vascular Endothelial Growth Factor B Market Size Growth Rate by Product
      • 1.4.2 Aflibercept
      • 1.4.3 Aflibercept Biosimilar
      • 1.4.4 CSL-346
      • 1.4.5 Others
    • 1.5 Market by End User
      • 1.5.1 Global Vascular Endothelial Growth Factor B Market Size Growth Rate by End User
      • 1.5.2 Rectal Cancer
      • 1.5.3 Retinal Vein Occlusion
      • 1.5.4 Diabetic Nephropathy
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Vascular Endothelial Growth Factor B Market Size
      • 2.1.1 Global Vascular Endothelial Growth Factor B Revenue 2014-2025
      • 2.1.2 Global Vascular Endothelial Growth Factor B Sales 2014-2025
    • 2.2 Vascular Endothelial Growth Factor B Growth Rate by Regions
      • 2.2.1 Global Vascular Endothelial Growth Factor B Sales by Regions
      • 2.2.2 Global Vascular Endothelial Growth Factor B Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Vascular Endothelial Growth Factor B Sales by Manufacturers
      • 3.1.1 Vascular Endothelial Growth Factor B Sales by Manufacturers
      • 3.1.2 Vascular Endothelial Growth Factor B Sales Market Share by Manufacturers
      • 3.1.3 Global Vascular Endothelial Growth Factor B Market Concentration Ratio (CR5 and HHI)
    • 3.2 Vascular Endothelial Growth Factor B Revenue by Manufacturers
      • 3.2.1 Vascular Endothelial Growth Factor B Revenue by Manufacturers (2014-2019)
      • 3.2.2 Vascular Endothelial Growth Factor B Revenue Share by Manufacturers (2014-2019)
    • 3.3 Vascular Endothelial Growth Factor B Price by Manufacturers
    • 3.4 Vascular Endothelial Growth Factor B Manufacturing Base Distribution, Product Types
      • 3.4.1 Vascular Endothelial Growth Factor B Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Vascular Endothelial Growth Factor B Product Type
      • 3.4.3 Date of International Manufacturers Enter into Vascular Endothelial Growth Factor B Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Vascular Endothelial Growth Factor B Sales by Product
    • 4.2 Global Vascular Endothelial Growth Factor B Revenue by Product
    • 4.3 Vascular Endothelial Growth Factor B Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Vascular Endothelial Growth Factor B Breakdown Data by End User

    6 North America

    • 6.1 North America Vascular Endothelial Growth Factor B by Countries
      • 6.1.1 North America Vascular Endothelial Growth Factor B Sales by Countries
      • 6.1.2 North America Vascular Endothelial Growth Factor B Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Vascular Endothelial Growth Factor B by Product
    • 6.3 North America Vascular Endothelial Growth Factor B by End User

    7 Europe

    • 7.1 Europe Vascular Endothelial Growth Factor B by Countries
      • 7.1.1 Europe Vascular Endothelial Growth Factor B Sales by Countries
      • 7.1.2 Europe Vascular Endothelial Growth Factor B Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Vascular Endothelial Growth Factor B by Product
    • 7.3 Europe Vascular Endothelial Growth Factor B by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Vascular Endothelial Growth Factor B by Countries
      • 8.1.1 Asia Pacific Vascular Endothelial Growth Factor B Sales by Countries
      • 8.1.2 Asia Pacific Vascular Endothelial Growth Factor B Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Vascular Endothelial Growth Factor B by Product
    • 8.3 Asia Pacific Vascular Endothelial Growth Factor B by End User

    9 Central & South America

    • 9.1 Central & South America Vascular Endothelial Growth Factor B by Countries
      • 9.1.1 Central & South America Vascular Endothelial Growth Factor B Sales by Countries
      • 9.1.2 Central & South America Vascular Endothelial Growth Factor B Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Vascular Endothelial Growth Factor B by Product
    • 9.3 Central & South America Vascular Endothelial Growth Factor B by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Vascular Endothelial Growth Factor B by Countries
      • 10.1.1 Middle East and Africa Vascular Endothelial Growth Factor B Sales by Countries
      • 10.1.2 Middle East and Africa Vascular Endothelial Growth Factor B Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Vascular Endothelial Growth Factor B by Product
    • 10.3 Middle East and Africa Vascular Endothelial Growth Factor B by End User

    11 Company Profiles

    • 11.1 Alteogen Inc
      • 11.1.1 Alteogen Inc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Alteogen Inc Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Alteogen Inc Vascular Endothelial Growth Factor B Products Offered
      • 11.1.5 Alteogen Inc Recent Development
    • 11.2 CSL Ltd
      • 11.2.1 CSL Ltd Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 CSL Ltd Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 CSL Ltd Vascular Endothelial Growth Factor B Products Offered
      • 11.2.5 CSL Ltd Recent Development
    • 11.3 Eli Lilly and Company
      • 11.3.1 Eli Lilly and Company Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Eli Lilly and Company Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Eli Lilly and Company Vascular Endothelial Growth Factor B Products Offered
      • 11.3.5 Eli Lilly and Company Recent Development
    • 11.4 Formycon AG
      • 11.4.1 Formycon AG Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Formycon AG Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Formycon AG Vascular Endothelial Growth Factor B Products Offered
      • 11.4.5 Formycon AG Recent Development
    • 11.5 Regeneron Pharmaceuticals Inc
      • 11.5.1 Regeneron Pharmaceuticals Inc Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Regeneron Pharmaceuticals Inc Vascular Endothelial Growth Factor B Products Offered
      • 11.5.5 Regeneron Pharmaceuticals Inc Recent Development

    12 Future Forecast

    • 12.1 Vascular Endothelial Growth Factor B Market Forecast by Regions
      • 12.1.1 Global Vascular Endothelial Growth Factor B Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Vascular Endothelial Growth Factor B Revenue Forecast by Regions 2019-2025
    • 12.2 Vascular Endothelial Growth Factor B Market Forecast by Product
      • 12.2.1 Global Vascular Endothelial Growth Factor B Sales Forecast by Product 2019-2025
      • 12.2.2 Global Vascular Endothelial Growth Factor B Revenue Forecast by Product 2019-2025
    • 12.3 Vascular Endothelial Growth Factor B Market Forecast by End User
    • 12.4 North America Vascular Endothelial Growth Factor B Forecast
    • 12.5 Europe Vascular Endothelial Growth Factor B Forecast
    • 12.6 Asia Pacific Vascular Endothelial Growth Factor B Forecast
    • 12.7 Central & South America Vascular Endothelial Growth Factor B Forecast
    • 12.8 Middle East and Africa Vascular Endothelial Growth Factor B Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Vascular Endothelial Growth Factor B Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Vascular Endothelial Growth Factor B market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Vascular Endothelial Growth Factor B market based on company, product type, end user and key regions.

      This report studies the global market size of Vascular Endothelial Growth Factor B in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Vascular Endothelial Growth Factor B in these regions.
      This research report categorizes the global Vascular Endothelial Growth Factor B market by top players/brands, region, type and end user. This report also studies the global Vascular Endothelial Growth Factor B market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Alteogen Inc
      CSL Ltd
      Eli Lilly and Company
      Formycon AG
      Regeneron Pharmaceuticals Inc

      Market size by Product
      Aflibercept
      Aflibercept Biosimilar
      CSL-346
      Others
      Market size by End User
      Rectal Cancer
      Retinal Vein Occlusion
      Diabetic Nephropathy
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Vascular Endothelial Growth Factor B market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Vascular Endothelial Growth Factor B market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Vascular Endothelial Growth Factor B companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Vascular Endothelial Growth Factor B submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Vascular Endothelial Growth Factor B are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Vascular Endothelial Growth Factor B market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now